WOONSOCKET, RI-Despite stiff competition over generic drugs from rival chains, drugstore giant CVS said sales were up 24.3% to $4.4 billion in September, rising nearly $1 billion over the $3.5 billion in sales for the same period a year earlier. Sales at stores open at least a year were also up by 8.8% in the five weeks ended Sept. 30, the company said.

The Woonsocket, RI drugstore chain took the unusual step of announcing its September results after rival Wal-Mart said it plans to begin offering some generic drugs at $4 per prescription. Thomas M. Ryan, chairman, president and chief executive officer of CVS Corp., said in a conference call that those 300 generic drugs represent less than 5% of the firm’s total pharmacy sales and 24% of its prescriptions.

Helped by the June acquisition of 701 Sav-On and Osco drugstores, CVS total sales soared 24.9% during the third quarter, rising to $11.2 billion from $9 billion during the same quarter a year earlier.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.